HOME >> BIOLOGY >> NEWS
Major boost for European zebrafish research

The zebrafish, a popular aquarium fish, is ideally suited to study the fundamental processes underlying embryonic development and the genetic basis of diseases. In recent years it has become one of the favourite model organisms of academic scientists and the biotech industry, and deciphering of its genome is already underway.

In the face of strong transatlantic competition, the European Commission has now decided to boost European zebrafish research by making it a flagship project of its 6th Framework Programme. The Integrated Project, ZF-MODELS, will bring together 15 leading European research institutions (see list below). Over five years, these institutions will receive a total budget of 12,400,000 Euros. 12,000,000 Euros will be contributed by the European Commission and 400,000 Euros by the Swiss National Science Foundation.

The partners of the ZF-MODELS project will join forces to work towards a common goal: to gain new insights into the genetic control of fundamental biological processes relevant for human disease, such as development, physiology and behaviour. The results, they hope, will form a basis for the development of new or improved therapies. Targets of the project will be common diseases such as cancer, neurodegenerative diseases, muscular dystrophies, eye diseases and behavioural disorders, as well as resistance to infections and wound healing.

To reach its aims the project will use advanced scientific tools that have only recently been developed by zebrafish researchers, and apply them on a massive scale and in an integrated fashion. Highlights of the project will include:

Mutagenesis projects that will bring together scientists from all over Europe to examine zebrafish carrying genetic mutations. In addition to the mutants with defects in early development identified in previous projects, a focus will be on mutations that affect the adult fish, since these are of special interest for human diseases.


'"/>

Contact: Dr. Ralf Dahm - Project Manager
ralf.dahm@tuebingen.mpg.de
49-7071-601-444
Max-Planck-Gesellschaft
9-Feb-2004


Page: 1 2

Related biology news :

1. Major scientific discovery in cancer research to be honored
2. Major U.S. environmental policy bears scrutiny in midlife
3. Major mutations, not many small changes, might lead way to new species
4. Major new finding on genetics of Parkinsons disease zeroes in on activity of alpha synuclein
5. Major stress during pregnancy linked to autism
6. Major fossil find reveals Asian origins of salamanders
7. Major unique new study shows infrequent inspections lead to greater stream pollution
8. Major new initiative to resolve structure of protein families
9. Major air pollution study launched
10. Major grant to aid McGill University professors efforts to improve school science teaching
11. Major grants support immunology, transplant and diabetes research at the University of Chicago

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. ... the global economic downturn will only increase price pressures overall for the industry. The ... value from every product launch is critical. However, history shows that only a third ...
(Date:7/4/2020)... ... , ... Aesthetics Biomedical (ABM), a leading aesthetics product development ... the products and treatments developed, but also the dedicated team behind the brands ... built by ABM have received several honors already for 2020, each of which ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in ... Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... up to three different materials for use with CRM, neurostimulation, vascular, and related ... materials to meet specific design requirements, performance, and cost criteria; especially where solid ...
(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... Join experts ... John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... the regulating body in China for drugs and medical devices. Specifically, for medical devices, ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode ... significant expansion of laboratory operations through its COVID-19 testing service, Bode-CARES . ... , Bode-CARES provides a turnkey solution that includes a comprehensive ...
Breaking Biology Technology:
Cached News: